bioRxivBiochemistryPreprint
Evaluation of Thiol-Mediated Uptake in VHL-Based PROTACs
Abstract
Modification of biologically active molecules with 1,2-dithiolane derivatives constitutes a promising strategy to increase the cellular uptake of compounds by leveraging thiol-mediated uptake pathways. In this study, we evaluate the effect of introducing 1,2-dithiolane handles to von Hippel-Lindau (VHL)-based proteolysis targeting chimeras (PROTACs) on their cytotoxic properties. Starting from a previous molecular design, two sets of derivatives with 1,2-dithiolane handles and control compounds comprising the corresponding carbon-equivalents were synthesized and studied for their anticancer properties. Increased or equipotent cytotoxicity towards cancer cells (HeLa) was observed for several derivatives compared to the parent compound. Especially for lipoic acid derivatives, and the corresponding all-carbon derivatives, a significant increase in cytotoxicity compared to the unfunctionalized compound was observed. These results suggest effects other than or in addition to thiol-mediated uptake for acylated PROTAC derivatives. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=113 SRC="FIGDIR/small/692502v1_ufig1.gif" ALT="Figure 1"> View larger version (12K): org.highwire.dtl.DTLVardef@b2943aorg.highwire.dtl.DTLVardef@21777aorg.highwire.dtl.DTLVardef@12afe24org.highwire.dtl.DTLVardef@1931e4b_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- research focus: drug response / drug discovery
- research focus: cancer & tumor microenvironment
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- PROxAb Shuttle: A non-covalent plug-and-play platform for the rapid generation of tumor-targeting antibody-PROTAC conjugates
H. Schneider, S. Jaeger, … M. Rieker·bioRxiv·Sep 29, 2023
- PROTAC-Driven Protective Therapy increases the therapeutic window of anticancer drugs
Lucía Simón-Carrasco, Soledad Raya, … Andres Joaquin Lopez-Contreras·bioRxiv·Jan 13, 2026
- Structure-guided design and optimization of covalent VHL-targeted sulfonyl fluoride PROTACs
Rishi R. Shah, Elena De Vita, … Edward W. Tate·Journal of Medicinal ChemistryPeer-reviewed·Mar 13, 2024
- PROTAC-mediated dual degradation of BCL-xL and BCL-2 is a highly effective therapeutic strategy in small-cell lung cancer
- Structural modification of naturally-occurring phenolics as a strategy for developing cytotoxic molecules towards cancer cells
P. A. Olim, R. B. Pereira, … D. M. Pereira·Archiv der PharmaziePeer-reviewed·Oct 11, 2023
- HDLs extract lipophilic drugs from cells
A. Zheng, G. Dubuis, … C. Widmann·bioRxiv·Dec 8, 2020